Sort
85,873 grants matching “alzheimers”
Learning the Regulatory Code of Alzheimer's Disease Genomes
$1,139,701Towfique Raj · Icahn School Of Medicine At Mount Sinai · U01 · FY2020 · AG
Molecular Genetics Of Scrapie Pathogenesis
$1,139,579Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Genetic Studies of Dementia in the Amish
$1,139,575Jonathan L. Haines · Vanderbilt University · R01 · FY2011 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease
$1,139,520Eric E Schadt · Icahn School Of Medicine At Mount Sinai · U01 · FY2016 · AG
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)
$1,139,473Jeffrey H. Price · Vala Sciences, Inc. · R44 · FY2024 · MH
Deciphering innate immune signaling mechanisms in glial cells linking lifetime environmental exposures to neuroinflammation, protein aggregation and neurodegeneration in Parkinsons disease
$1,139,354Ronald B Tjalkens · Colorado State University · R35 · FY2023 · ES
Early Age-Related Hearing Loss Investigation (EARHLI): A Randomized Controlled Trial to Assess Mechanisms Linking Early Age-Related Hearing Loss and Alzheimer's Disease and Related Dementias
$1,139,335Justin Scott Golub · Columbia University Health Sciences · R01 · FY2025 · AG
Biological And Biochemical Characterization Of Sigma Receptors
$1,139,116Tsung-Ping Ping Su · National Institute On Drug Abuse · ZIA · FY2019 · DA
Molecular Genetics Of Early Eye Development
$1,139,032Stanislav I Tomarev · National Eye Institute · ZIA · FY2024 · EY
Genetically Informed Studies of Social Connectedness and Health
$1,138,955David A Sbarra · University Of Arizona · R01 · FY2024 · AG
Contribution of child development, biological aging, and beta-amyloid to cognitive function of the Louisville twins at midlife
$1,138,735Christopher Ryan Beam · University Of Southern California · R01 · FY2019 · AG
NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORYCONTRACT TYPE: COST, OPTIONPERIOD OF PERFORMANCE: 09/01/2021 TO 08/31/2022ADDITIONAL FUNDING
$1,138,655Rashed Nagra · Greater Los Angeles Veterans Research And Education Foundation · N01 · FY2024 · DA
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial
$1,138,419Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2020 · AG
Core B: Clinical Core
$1,138,201Constantine G Lyketsos · Johns Hopkins University · P30 · FY2022 · AG
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia
$1,138,042Konstantinos Arfanakis · Rush University Medical Center · U01 · FY2025 · NS
Detection of Prions
$1,137,875Byron Caughey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Epigenetics Biomarker of Post Operative Delirium and Long Term Cognitive Decline among Elderly Dementia Patients
$1,137,836Gen Shinozaki · Stanford University · R01 · FY2024 · AG
Neuronal Immunity in HIV Dementia
$1,137,512Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2007 · NS
Long-Term Nicotine Treatment of Mild Cognitive Impairment
$1,137,207Paul A. Newhouse · Vanderbilt University Medical Center · R01 · FY2019 · AG
MRI, Genetics & Cognitive Precursors of AD & Dementia
$1,136,978Philip A Wolf · Boston University Medical Campus · R01 · FY2009 · AG
Boston University Alzheimer's Disease Core Center
$1,136,977Neil W. Kowall · Boston University Medical Campus · P30 · FY2011 · AG
Genomic Convergence in Alzheimer Disease
$1,136,836Margaret A Pericak-Vance · University Of Miami School Of Medicine · R01 · FY2012 · AG
Core-003
$1,136,511Bruce T Lamb · Indiana University Indianapolis · U54 · FY2021 · AG
Clinical Core
$1,136,251Sarah B Berman · University Of Pittsburgh At Pittsburgh · P30 · FY2025 · AG
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$1,135,999Madhav Thambisetty · National Institute On Aging · ZIA · FY2019 · AG